CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis
Authors
Barbara Baka-Ćwierz
Teresa Belica-Wdowik
+26 more
Jolanta Białkowska
Iwona Buczyńska
Jolanta Citko
Agnieszka Czauż-Andrzejuk
Zbigniew Deroń
Beata Dobracka
Dorota Dybowska
Robert Flisiak
Aleksander Garlicki
Waldemar Halota
Ewa Janczewska
Jerzy Jaroszewicz
Jakub Klapaczyński
Rafał Krygier
Łukasz Laurans
Beata Lorenc
Włodzimierz Mazur
Paweł Pabjan
Małgorzata Pawłowska
Anna Piekarska
Krzysztof Simon
Marek Sitko
Krzysztof Tomasiewicz
Olga Tronina
Magdalena Tudrujek-Zdunek
Dorota Zarębska-Michaluk
Publication date
1 January 2020
Publisher
'Elsevier BV'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Jagiellonian Univeristy Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ruj.uj.edu.pl:item/256939
Last time updated on 12/12/2020